Horizon Pharma, Inc.
NASDAQ: HZNP
$109.76
+$1.74 (+1.6%)
Closing price September 21, 2021
The drastic changes in the way business is being done now may be here for good. These four Jefferies growth stock picks look poised to advance into the future and have some big upside to the firm's...
4 months ago
Last Updated: 4 months ago
Friday's top analyst upgrades and downgrades included AerCap, Barclays, Denny's, DocuSign, Intercontinental Hotels, Lennar, Luminar Technologies and Quest Diagnostics.
6 months ago
Last Updated: 6 months ago
The MSCI indexes are rebalanced twice a year, and at the end of November, a huge rebalance is set to occur. That means some major buying in some very well-known companies.
10 months ago
Last Updated: 4 months ago
These five high-conviction health care stock picks from the analysts at Jefferies all make sense for investors looking to gain exposure to a sector that should continue to do well the rest of 2020...
11 months ago
These four high-conviction health care stock ideas from the analysts at Jefferies all make sense for investors looking to gain exposure to a sector that should continue to do well the rest of 2020...
1 year ago
Horizon Pharma shares exploded on Thursday after the firm announced results from its late-stage trial evaluating teprotumumab for the treatment of active thyroid eye disease.
2 years ago
Last Updated: 1 year ago
The top analyst upgrades, downgrades and other research calls from Wednesday included Altice, Blue Apron, CubeSmart, Horizon Pharma, KB Home, Las Vegas Sands, Mylan and Switch.
2 years ago
Last Updated: 1 year ago
The top analyst upgrades, downgrades and other research calls from Monday include Applied Materials, Barrick Gold, Comcast, GoDaddy, Intel, PG&E, Qualcomm and Sirius XM.
3 years ago
Last Updated: 1 year ago
Here are 10 top Ireland-based public companies with shares that are traded in the United States that may be worth putting on a watchlist.
3 years ago
Last Updated: 1 year ago
These five top companies with different health care businesses all can provide nice exposure to the sector in growth portfolios. All are rated Buy at Jefferies and make sense now.
3 years ago
Last Updated: 1 year ago
24/7 Wall St. screened the Stifel specialty pharmaceutical list and found five stock rated Buy that have massive upside potential and probably don’t have the investment risk of some of the more...
3 years ago
Last Updated: 1 year ago
The top analyst upgrades, downgrades and other research calls include Archer Daniels Midland, BlackRock, DexCom, Mallinckrodt, McDonald's, Philip Morris and Redfin.
3 years ago
Last Updated: 1 year ago
Horizon Pharma released a better than expected quarterly earnings report before the markets opened on Monday.
4 years ago
Last Updated: 1 year ago
The analysts at Stifel have focused on biotech and specialty pharma companies that not only have data that could prove to be huge, but they are offering aggressive accounts the best entry points in...
4 years ago
Last Updated: 1 year ago
Pandora, Hertz, Horizon Pharma, and Chicago Bridge & Iron all posted new 52-week lows on Tuesday.
4 years ago
Last Updated: 1 year ago